SecBot SecBot

EUDA

EUDA Health Holdings Ltd
Nasdaq· Services-Health Services· Inc. D8· CIK 0001847846 Healthcare & Medical Devices
$14.46 +1.68 (+13.15%)
Oct 26 4:00 PM ET · prev $12.78
Market cap
$40.0M
Nano cap
Median target
$55.00
+280% · range $55.00–55.00
1 year
−67.1%
from $44.00 · Oct 27
30 days
−10.7%
from $16.20
52-week range
$5.26–68.60
−79% from high · low Apr 17
Avg volume 20D
39.3K
Oct 20 spike 120.2K
Short interest
🔒 Subscribers only
Filing reports
6
analyzed by SecBot
SecBot read BEARISH 5 reports · 90 days
Balance 2 bearish · 0 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 3/5
Strongest BEARISH EUDA Health Holdings filed a 6-K furnishing proxy materials for an October 30, 2026 extraordinary general…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • TrendDOWNTREND

    7% below its 50-day average.

Who's buying

13F
Top holderSharesValue
UBS Group AG22$308.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Mar 2026
12-month targets · 1 analysts

Price is below the lowest target. Median implies +280%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Mar 9, 2026Greenridge Global
MAINTAIN
MAINTAINBuy

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY$1.60$1.60–$1.60-52.9%$27.2M
Next FY———$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 26, 2026
Announcement
EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
SINGAPORE, AUGUST, Aug. 26, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based…
Jul 30, 2026
Announcement
EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
SINGAPORE, July 30, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided…
Jul 14, 2026
Trading halt
Halt Resumed: EUDA — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-07-14T14:19:02.000Z | Resumed 2026-07-14T14:24:02.000Z
Jul 14, 2026
Trading halt
Trading Halt: EUDA — LUDP (Volatility Trading Pause)
EUDA Health Hldgs Ltd Ord Shs | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Jun 1, 2026
Press release
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive…

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Trading halts
Jul 14, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 13, 2026 SEC
EUDA Health Holdings filed a 6-K furnishing proxy materials for an October 30, 2026 extraordinary general meeting. The…
6-K — Impact 6/10
Oct 13, 2026 SEC
EUDA Health Holdings Ltd filed an amendment to its Amended and Restated Memorandum and Articles of Association with…
6-K — Impact 2/10
Aug 26, 2026 Press
EUDA Health subsidiary Melana International won the SME100 Awards 2026 Singapore, a non-financial recognition for its…
Impact 2/10
Aug 26, 2026 Announcement
EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
SINGAPORE, AUGUST, Aug. 26, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“E
Aug 11, 2026 SEC
EUDA Health Holdings Ltd's shelf registration statement (File No. 333-296224) on Form F-3 was declared effective by…
EFFECT — Impact 5/10
Apr 28, 2026 Press
EUDA Health announced that its partner Shenzhen Inno Immune received government approval for a TCR-T cell therapy R&D…
Impact 3/10

SecBot reports

6 filings · 4 press releases · 1 bullish · 2 bearish · 3 neutral
All EUDA filing & press-release reports (10)